Changes to our trading names and address – MSD and Organon & Co. read more

Changes to our trading names and address

Please note that in 2021, MSD will be spinning off products from its women’s health, legacy brands, and biosimilars franchises into a new independent, publicly traded company known as Organon & Co.

Due to legal entity separation in advance of this spin off, we now have two UK registered businesses, MSD and Organon. Organon & Co. is a wholly owned subsidiary of Merck & Co., Inc. of Kenilworth, New Jersey, USA.

As a result of the future spin-off of Organon, as well as our head offices moving to London in early 2021, you will begin to see some changes to references to our products, contact details, materials and statements over the coming months.


MSD is proud to be investing in the UK.

MSD announces location of new state-of-the-art Discovery Research Centre and UK Headquarters in Central London

LEARN MORE

Addressing antibiotic resistance is more critical than ever. Here’s why.

LEARN MORE

How MSD is responding to the global pandemic, COVID-19

LEARN MORE

Come as you are

LGBTQ+ employees around the world share personal stories about what it means to bring their whole selves to work

LEARN MORE

Meet MSD doctor and volunteer Dr. Mo Ali:

"We are here to serve the people we look after, I cannot stand by and watch this."

READ MORE HERE

Learn about how we invent together

Portraits of Invention tells the story of how our people and heritage at MSD enable us to continue ‘Inventing Together’

WATCH OUR CAMPAIGN HERE

Our discovery research and collaboration is growing

We are using novel techniques with cutting-edge technology to push boundaries at the forefront of science

WATCH OUR VIDEOS

GB-NON-03270
Date of Preparation: September 2020